The U.S. bone grafts and substitutes market size surpassed USD 840 million in 2025 and is predicted to reach around USD 1381.36 million by 2035, registering a CAGR of 5.1% from 2026 to 2035.The market is mainly influenced by an older population prone to bone issues, a growing number of orthopedic conditions, and a rise in dental implant surgeries.

U.S. Bone Grafts and Substitutes Market Statical Scope

The market is vital because of the increasing need to address orthopedic conditions, spinal problems, and fractures in an aging demographic. It plays a key role in promoting bone healing, shortening recovery times after surgery, and supporting new, less invasive dental procedures that use bone grafts. The market benefits from improvements in synthetic grafts, biological grafts, and antibiotic-releasing fillers that enhance patient results and lower infection risks.

Patients and healthcare providers strongly favor less invasive surgeries that lead to quicker recoveries and reduced discomfort. Many individuals experience musculoskeletal issues, including osteoarthritis , spinal injuries, and fractures from trauma, which require advanced grafting options.

U.S. Bone Grafts and Substitutes Market Share, By Material Type, 2025 (%)

• Allograft - The allograft segment holds a 58% share in the U.S. market. Its natural, human-derived makeup offers excellent osteoconductivity and biocompatibility. This segment is dominant because it eliminates the need for a second surgery to collect bone, which reduces patient morbidity and surgical time.
• Synthetic - The synthetic segment accounts for 42% of the market and is essential due to its better availability, lower risk of disease transmission, and improvements in bio-compatible materials. Its advantages include an unlimited supply, no need for a second surgical site for harvesting, and lower costs compared to allografts.

U.S. Bone Grafts and Substitutes Market Share, By Application, 2025 (%)

• Craniomaxillofacial - The craniomaxillofacial (CMF) segment, with an 11% share, is a key growth factor in the U.S. market. This is driven by the increasing cases of facial trauma, more corrective surgeries, and the demand for advanced dental implant reconstruction. It is expected to generate significant revenue, supported by 3D printing technology and specialized biocompatible materials.
• Dental - The dental segment, holding a 19% share, is a major contributor to the U.S. bone grafts market, due to the high number of dental implant surgeries and the need for socket preservation to avoid bone loss after tooth extraction. The growing interest in cosmetic dentistry and advanced, minimally invasive bone regeneration techniques is driving this rapidly expanding sector.

Top Companies in the U.S. Bone Grafts and Substitutes Market

• AlloSource
• DePuy Synthes (Johnson & Johnson)
• Baxter
• NuVasive, Inc.
• Smith + Nephew
• Medtronic
• Orthofix Medical, Inc.
• OST Laboratories
• Zimmer Biomet
• Geistlich Pharma AG
• Stryker
• Biobank

Segments Covered in the Report

By Material Type

• Allograft
• Synthetic

By Application

• Craniomaxilofacial
• Dental
• Foot and Ankle
• Joint Reconstruction
• Long Bone
• Spinal Fusion